Sejal King, PharmD, is currently the Director of Medical Science Liaisons specializing in Rare Disease, Ophthalmology, and Endocrinology at Amgen. They previously held positions as a Regional Medical Director and Director of Medical Affairs Training Excellence at Horizon from 2019 to 2023, as well as a Medical Science Liaison at Flexion Therapeutics from 2016 to 2019. Sejal's early career included a role as a Multidisciplinary Fellow and later a Medical Information Therapeutic Manager at Novo Nordisk from 2014 to 2015. They earned their Doctor of Pharmacy degree from the University of the Sciences, where they studied from 2008 to 2014.
This person is not in any teams
This person is not in any offices